Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg
Product details
Registration number: SIN14589P
Classification: Prescription Only
Active ingredients:
- Imipenem Monohydrate 530mg corresponding to Imipenem
- Sodium Cilastatin 530mg corresponding to Cilastatin
Strength:
- 500mg
- 500mg
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: ALLIANCE PHARM PTE. LTD.
ATC code: J01DH51
HSA approval date: 13 August 2014
Manufacturer(s):
- ACS Dobfar S.p.A
- ACS Dobfar SpA (Intermediate)
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14589P
Classification: Prescription Only
What active ingredients and strength are recorded for Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Imipenem Monohydrate 530mg corresponding to Imipenem
- Sodium Cilastatin 530mg corresponding to Cilastatin
Strength:
- 500mg
- 500mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg?
According to the HSA dataset updated 7 August 2026:
Registrant: ALLIANCE PHARM PTE. LTD.
Which manufacturers and countries are listed for Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- ACS Dobfar S.p.A
- ACS Dobfar SpA (Intermediate)
Manufacturing country/countries: ITALY
Where can I look up Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14589P or the exact product name Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg. The general register link does not preselect this product.
What are the source dates for this Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Imipenem/Cilastatin Labatec IV powder for Injection 500mg/500mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14589P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)